<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Virazole; Ribavirin" /><meta name="IX" content="Virazole; Ribavirin" /><title>Virazole®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP3907-virazole.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP3907-virazole.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP3907-virazole.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 07 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP3253-infections.htm">5 Infections</a> &gt; <a href="PHP3742-antiviral-drugs.htm">5.3 Antiviral drugs</a> &gt; <a href="PHP3901-respiratory-syncytial-virus.htm">5.3.5 Respiratory syncytial virus</a> &gt; <a href="PHP3904-ribavirin.htm">RIBAVIRIN(Tribavirin)</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP3902-palivizumab.htm" title="Previous: PALIVIZUMAB">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP3908-antiprotozoal-drugs.htm" title="Next: 5.4 Antiprotozoal drugs">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a386021.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ribavirin</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Anti-infective Agents 8:00 &gt; Antivirals 8:18 &gt; Nucleosides and Nucleotides 8:18.32</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/1685-r.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Ribavirin</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: R &gt; Interactions of Ribavirin</p></div></li></ul><ul><li><h3>British National Formulary (5)</h3></li><li><a href="PHP3880-chronic-hepatitis-c.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">5.3.3.2 Chronic hepatitis C</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs &gt; 5.3.3 Viral hepatitis</p></div></li><li><a href="PHP3901-respiratory-syncytial-virus.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">5.3.5 Respiratory syncytial virus</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs</p></div></li><li><a href="PHP3904-ribavirin.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">RIBAVIRIN</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs &gt; 5.3.5 Respiratory syncytial virus</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22ribavirin%22%22tribavirin%22%22ribavirin%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (5)</a></li></ul><ul><li><h3>BNF for Children (5)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP13036-viral-hepatitis.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">5.3.3 Viral hepatitis</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP13045-respiratory-syncytial-virus.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">5.3.5 Respiratory syncytial virus</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP13048-ribavirin.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">RIBAVIRIN</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs &gt; 5.3.5 Respiratory syncytial virus</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22ribavirin%22%22tribavirin%22%22ribavirin%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (5)</a></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0017s0074.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ribavirin</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; R</p></div></li></ul><ul><li><h3>Kucers' the Use of Antibiotics (7)</h3></li><li><a href="http://www.medicinescomplete.com/mc/kucers/2010/ribavirin_and_viramidine_description.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Description</a><div class="breadcrumb"><p><strong>Kucers' the Use of Antibiotics</strong> &gt; Anti-Viral Drugs &gt; Agents Active Against Hepatitis Viruses &gt; 252 Ribavirin and Viramidine</p></div></li><li><a href="http://www.medicinescomplete.com/mc/kucers/2010/ribavirin_and_viramidine_antimicrobial_activity.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Antimicrobial activity</a><div class="breadcrumb"><p><strong>Kucers' the Use of Antibiotics</strong> &gt; Anti-Viral Drugs &gt; Agents Active Against Hepatitis Viruses &gt; 252 Ribavirin and Viramidine</p></div></li><li><a href="http://www.medicinescomplete.com/mc/kucers/2010/ribavirin_and_viramidine_mechanism_of_drug_action.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Mechanism of drug action</a><div class="breadcrumb"><p><strong>Kucers' the Use of Antibiotics</strong> &gt; Anti-Viral Drugs &gt; Agents Active Against Hepatitis Viruses &gt; 252 Ribavirin and Viramidine</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22ribavirin%22%22tribavirin%22%22ribavirin%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (7)</a></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/1685-r.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ribavirin</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antivirals &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/999918-n4396-l.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ribavirin Nebuliser Solution BP 2012 (Pharmacopoeial)</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Preparations &gt; By country &gt; Pharmacopoeial &gt; R</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/08198.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ribavirin</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; R &gt; RI</p></div></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-R15.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ribavirin</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; R</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E2E3E0R0D872.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Ribavirin</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; R</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>RIBAVIRIN<span class="cAB"><strong>(Tribavirin)</strong></span></h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int953-ribavirin.htm">Ribavirin</a>).</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT">severe respiratory syncytial virus bronchiolitis in infants and children; in combination with peginterferon alfa or interferon alfa for chronic hepatitis C in patients without liver decompensation (see also <a title="BNF:sub-sub-section: Chronic hepatitis C" href="PHP3880-chronic-hepatitis-c.htm">section 5.3.3.2</a>)</p></div></div><div class="cL"><h2 class="cM">Cautions </h2><div class="cG"><div class="cE"><h3 class="cT">Specific cautions for inhaled treatment</h3> <p class="cT">Maintain standard supportive respiratory and fluid management therapy; monitor electrolytes closely; monitor equipment for precipitation; pregnant women (and those planning pregnancy) should avoid exposure to aerosol</p></div></div><div class="cG"><div class="cE"><h3 class="cT">Specific cautions for oral treatment</h3> <p class="cT">Exclude pregnancy before treatment; effective contraception essential during treatment and for 4 months after treatment in women and for 7 months after treatment in men; routine monthly pregnancy tests recommended; condoms must be used if partner of male patient is pregnant (ribavirin excreted in semen); cardiac disease (assessment including ECG recommended before and during treatment—discontinue if deterioration); gout; determine full blood count, platelets, electrolytes, serum creatinine, liver function tests and uric acid before starting treatment and then on weeks 2 and 4 of treatment, then as indicated clinically—adjust dose if adverse reactions or laboratory abnormalities develop (consult product literature); eye examination recommended before treatment; eye examination also recommended during treatment if pre-existing ophthalmological disorder or if decrease in vision reported—discontinue treatment if ophthalmological disorder deteriorates or if new ophthalmological disorder develops; patients with a transplant —risk of rejection; test thyroid function before treatment and then every 3 months in children; risk of growth retardation in children, the reversibility of which is uncertain—if possible, consider starting treatment after pubertal growth spurt</p></div></div><p><strong>Interactions:</strong> Appendix 1 (ribavirin)</p></div><div class="cL"><h2 class="cM">Contra-indications </h2><div class="cG"><div class="cE"><h3 class="cT">Specific contra-indications for oral treatment</h3> <p class="cT">Severe cardiac disease, including unstable or uncontrolled cardiac disease in previous 6 months; haemoglobinopathies; severe debilitating medical conditions; autoimmune disease (including autoimmune hepatitis); uncontrolled severe psychiatric condition; history of severe psychiatric condition in children</p></div></div></div><div class="cL"><div class="cE"><h2 class="cN">Hepatic impairment </h2> <p class="cT">no dosage adjustment required; use oral ribavirin with caution in severe hepatic dysfunction or decompensated cirrhosis</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Renal impairment </h2> <p class="cT">plasma-ribavirin concentration increased; avoid oral ribavirin unless essential if eGFR less than 50 mL/minute/1.73 m<sup>2</sup>—monitor haemoglobin concentration closely</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Pregnancy </h2> <p class="cT">avoid; teratogenicity in <em>animal</em> studies; see also Cautions above</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Breast-feeding </h2> <p class="cT">avoid—no information available</p></div></div><div class="cL"><h2 class="cM">Side-effects </h2><div class="cG"><div class="cE"><h3 class="cT">Specific side-effects for inhaled treatment</h3> <p class="cT">Worsening respiration, bacterial pneumonia, and pneumothorax reported; rarely non-specific anaemia and haemolysis</p></div></div><div class="cG"><div class="cE"><h3 class="cT">Specific side-effects for oral treatment</h3> <p class="cT">Haemolytic anaemia (anaemia may be improved by epoetin); also (in combination with peginterferon alfa or interferon alfa) nausea, vomiting, dyspepsia, abdominal pain, flatulence, constipation, diarrhoea, colitis, chest pain, palpitation, tachycardia, peripheral oedema, changes in blood pressure, syncope, flushing, cough, dyspnoea, headache, dizziness, asthenia, impaired concentration and memory, sleep disturbances, abnormal dreams, anxiety, depression, suicidal ideation (more frequent in children), psychoses, dysphagia, weight loss, dysphonia, paraesthesia, hypoaesthesia, ataxia, hypertonia, influenza-like symptoms, thyroid disorders, hyperglycaemia, menstrual disturbances, breast pain, prostatitis, sexual dysfunction, micturition disorders, leucopenia, thrombocytopenia, lymphadenopathy, dehydration, hypocalcaemia, myalgia, arthralgia, hyperuricaemia, visual disturbances, eye pain, dry eyes, hearing impairment, tinnitus, earache, dry mouth, taste disturbances, mouth ulcers, stomatitis, glossitis, tooth disorder, gingivitis, alopecia, pruritus, dry skin, rash (including very rarely Stevens-Johnson syndrome and toxic epidermal necrolysis), increased sweating, psoriasis, photosensitivity, and acne; <em>less commonly</em> pancreatitis, gastro-intestinal bleeding, and hypertriglyceridaemia; <em>rarely</em> peptic ulcer, arrhythmias, cardiomyopathy, myocardial infarction, pericarditis, stroke, interstitial pneumonitis, pulmonary embolism, seizures, renal failure, vasculitis, rheumatoid arthritis, systemic lupus erythematosus, sarcoidosis, optic neuropathy, and retinal haemorrhage; <em>very rarely</em> aplastic anaemia and peripheral ischaemia; <em>in children</em> also growth retardation (including decrease in height and weight), pallor, tachypnoea, hyperkinesia, virilism, and skin discoloration</p></div></div></div><div class="cL"><h2 class="cM">Dose</h2><div class="cR"><ul><li><p>See preparations below</p></li></ul></div></div></div><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="PHP3905-copegus.htm#PHP3905-copegus" title="Copegus®">Copegus®</a></li><li><a href="PHP3906-rebetol.htm#PHP3906-rebetol" title="Rebetol®">Rebetol®</a></li></ul><div id="PHP3907-virazole" style="margin: 0 0 0 20px;"><h1 class="title">Virazole® <span>(<a href="PHP10005-index-of-manufacturers.htm#PHP10231">Meda</a>)</span><span> <img src="images/pom_l.png" alt="Prescription only medicine" /> <img src="images/rect_l.png" alt="Less suitable for prescribing" /></span></h1><div class="cU"><p><strong>Inhalation</strong>, ribavirin 6 g for reconstitution with 300 mL water for injections. Net price 3 × 6-g vials = £349.00</p><p class="cR"><strong>Dose </strong>bronchiolitis, <span class="cK">by aerosol inhalation</span><em> or </em><span class="cK">nebulisation</span> (via small particle aerosol generator) of solution containing 20 mg/mL for 12–18 hours for at least 3 days; max. 7 days</p></div></div></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP3902-palivizumab.htm">Previous: PALIVIZUMAB</a> | <a class="top" href="PHP3907-virazole.htm#">Top</a> | <a accesskey="]" href="PHP3908-antiprotozoal-drugs.htm">Next: 5.4 Antiprotozoal drugs</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>